Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects (Q36852591)
Jump to navigation
Jump to search
scientific article published on 14 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects |
scientific article published on 14 February 2013 |
Statements
1 reference
Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects (English)
1 reference
Benjamin F Cravatt
1 reference
Steven G Kinsey
1 reference
Laura E Wise
1 reference
Divya Ramesh
1 reference
Rehab Abdullah
1 reference
Dana E Selley
1 reference
Aron H Lichtman
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference